BRUSSELS, Nov 13 (Reuters) - Israeli drugmaker Teva (TEVA.TA), opens new tab is the target of an EU antitrust investigation over the possible abuse of its dominant position related to its multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback